期刊文献+

中药及保健食品中违禁添加7种降压类化学药物的HPLC-DAD法测定 被引量:19

Determination of Seven Anti-hypertension Chemical Drugs Added Illegally into Traditional Chinese Medicines and Health Food by HPLC-DAD
下载PDF
导出
摘要 建立了HPLC法同时测定中药及保健食品中可能违禁添加的7种降压类化学药物。采用C18色谱柱,以0.2%磷酸溶液-乙腈为流动相,梯度洗脱,检测波长220nm。阿替洛尔、盐酸可乐定、氢氯噻嗪、卡托普利、盐酸哌唑嗪、利血平和硝苯地平的线性范围分别为0.0284~2.84、0.029~2.9、0.053~5.3、0.054~5.45、0.054~5.4、0.034~3.38和0.031~3.12μg,回收率分别为99.7%、91.2%、99.5%、107.6%、108.7%、97.8%和106.1%,RSD分别为2.1%、3.5%、2.5%、3.8%、1.0%、4.2%和5.0%。 An HPLC-DAD method was established for the determination of seven anti-hypertension chemical drugs added illegally into traditional Chinese medicines and health food.A C18 column was used with the mobile phase of 0.2% phosphoric acid solution-acetonitrile by gradient elution at the detection wavelength of 220 nm.The calibration curves of atenolol,clonidine hydrochloride,hydrochorothiazide,captopril,prazosin hydrochloride,reserpine and nifedipine were linear in the ranges of 0.028 4-2.84,0.029-2.9,0.053-5.3,0.054-5.45,0.054-5.4,0.034-3.38 and 0.031-3.12 μg,respectively.The average recoveries were 99.7%,91.2%,99.5%,107.6%,108.7%,97.8% and 106.1%,with RSDs of 2.1%,3.5%,2.5%,3.8%,1.0%,4.2% and 5.0%,respectively.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2010年第8期601-603,共3页 Chinese Journal of Pharmaceuticals
基金 国家科技支撑计划药品安全关键技术研究课题(2006BAI14B03-2-3)
关键词 降血压类药物 中药 保健食品 高效液相色谱 测定 anti-hypertension traditional Chinese medicines health food HPLC determination
  • 相关文献

参考文献5

二级参考文献15

共引文献76

同被引文献215

引证文献19

二级引证文献159

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部